Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Astellas Licenses 4D’s Viral Vector In Gene Therapy Push In Rare Ophthalmic Disease
Pays $20m Upfront
Jul 12 2023
•
By
Ayisha Sharma
The R100 Vector Can Penetrate The Retina's Inner Limiting Membrane Barrier • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Deals
More from Business